| Circulating mutant DNA to assess tumor dynamics F Diehl, K Schmidt, MA Choti, K Romans, S Goodman, M Li, K Thornton, ... Nature medicine 14 (9), 985-990, 2008 | 3100 | 2008 |
| Detection and quantification of mutations in the plasma of patients with colorectal tumors F Diehl, M Li, D Dressman, Y He, D Shen, S Szabo, LA Diaz Jr, ... Proceedings of the National Academy of Sciences 102 (45), 16368-16373, 2005 | 1572 | 2005 |
| Comparative lesion sequencing provides insights into tumor evolution S Jones, W Chen, G Parmigiani, F Diehl, N Beerenwinkel, T Antal, ... Proceedings of the National Academy of Sciences 105 (11), 4283-4288, 2008 | 1009 | 2008 |
| Development of personalized tumor biomarkers using massively parallel sequencing RJ Leary, I Kinde, F Diehl, K Schmidt, C Clouser, C Duncan, A Antipova, ... Science translational medicine 2 (20), 20ra14-20ra14, 2010 | 691 | 2010 |
| BEAMing: single-molecule PCR on microparticles in water-in-oil emulsions F Diehl, M Li, Y He, KW Kinzler, B Vogelstein, D Dressman Nature methods 3 (7), 551-559, 2006 | 616 | 2006 |
| Antibody microarrays: an evaluation of production parameters W Kusnezow, A Jacob, A Walijew, F Diehl, JD Hoheisel Proteomics 3 (3), 254-264, 2003 | 413 | 2003 |
| Sensitive digital quantification of DNA methylation in clinical samples M Li, W Chen, N Papadopoulos, SN Goodman, NC Bjerregaard, ... Nature biotechnology 27 (9), 858, 2009 | 403 | 2009 |
| Detection of Tumor PIK3CA Status in Metastatic Breast Cancer Using Peripheral Blood MJ Higgins, D Jelovac, E Barnathan, B Blair, S Slater, P Powers, J Zorzi, ... Clinical cancer research 18 (12), 3462-3469, 2012 | 373 | 2012 |
| Analysis of mutations in DNA isolated from plasma and stool of colorectal cancer patients F Diehl, K Schmidt, KH Durkee, KJ Moore, SN Goodman, AP Shuber, ... Gastroenterology 135 (2), 489-498. e7, 2008 | 364 | 2008 |
| BEAMing up for detection and quantification of rare sequence variants M Li, F Diehl, D Dressman, B Vogelstein, KW Kinzler Nature methods 3 (2), 95-97, 2006 | 356 | 2006 |
| Identification of the binding site for a novel class of CCR2b chemokine receptor antagonists: binding to a common chemokine receptor motif within the helical bundle T Mirzadegan, F Diehl, B Ebi, S Bhakta, I Polsky, D McCarley, M Mulkins, ... Journal of Biological Chemistry 275 (33), 25562-25571, 2000 | 331 | 2000 |
| Manufacturing DNA microarrays of high spot homogeneity and reduced background signal F Diehl, S Grahlmann, M Beier, JD Hoheisel Nucleic acids research 29 (7), e38-e38, 2001 | 312 | 2001 |
| Characterizing the patterns of clonal selection in circulating tumor DNA from patients with colorectal cancer refractory to anti-EGFR treatment MP Morelli, MJ Overman, A Dasari, SMA Kazmi, T Mazard, E Vilar, ... Annals of Oncology 26 (4), 731-736, 2015 | 287 | 2015 |
| Performance of Streck cfDNA blood collection tubes for liquid biopsy testing I Medina Diaz, A Nocon, DH Mehnert, J Fredebohm, F Diehl, F Holtrup PloS one 11 (11), e0166354, 2016 | 202 | 2016 |
| Serial assessment of human tumor burdens in mice by the analysis of circulating DNA C Rago, DL Huso, F Diehl, B Karim, G Liu, N Papadopoulos, Y Samuels, ... Cancer research 67 (19), 9364-9370, 2007 | 185 | 2007 |
| Circulating Mutant DNA to Assess Tumor Dynamics F Diehl, L Diaz, KW Kinzler, B Vogelstein, K Schmidt US Patent App. 12/512,585, 2010 | 170 | 2010 |
| Identification of surface residues of the monocyte chemotactic protein 1 that affect signaling through the receptor CCR2 K Jarnagin, D Grunberger, M Mulkins, B Wong, S Hemmerich, C Paavola, ... Biochemistry 38 (49), 16167-16177, 1999 | 152 | 1999 |
| Repeated mutKRAS ctDNA measurements represent a novel and promising tool for early response prediction and therapy monitoring in advanced pancreatic cancer S Kruger, V Heinemann, C Ross, F Diehl, D Nagel, S Ormanns, ... Annals of Oncology 29 (12), 2348-2355, 2018 | 150 | 2018 |
| Digital quantification of mutant DNA in cancer patients F Diehl, LA Diaz Jr Current opinion in oncology 19 (1), 36-42, 2007 | 130 | 2007 |
| Actionable mutations in plasma cell-free DNA in patients with advanced cancers referred for experimental targeted therapies F Janku, P Angenendt, AM Tsimberidou, S Fu, A Naing, GS Falchook, ... Oncotarget 6 (14), 12809, 2015 | 101 | 2015 |
Kenneth KinzlerJohns Hopkins UniversityVerified email at jhmi.edu
